Inhibition of human platelet aggregation by monovalent antifibrinogen antibody fragments

D. M. Tollefsen, P. W. Majerus

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Abstract

Monovalent goat antibody fragments (Fab) that were monospecific for human fibrinogen were isolated by affinity chromatography on fibrinogen Sepharose and used as a direct probe for the involvement of fibrinogen in platelet aggregation and the release reaction. The antifibrinogen Fab inhibited aggregation of washed human platelets induced by thrombin (0.1-10 U/ml) by 50-95%, but had no effect on [14C] serotonin release and only a slight inhibitory effect on 125I thrombin binding to platelets. Inhibition of aggregation was not observed with nonimmune goat Fab or rabbit antihuman albumin Fab. About 40,000 125I labeled antifibrinogen Fab molecules per platelet were bound tightly at saturation to surface fibrinogen molecules. After washing the platelets once to remove unbound Fab, aggregation by subsequently added thrombin was no longer inhibited. The antifibrinogen Fab inhibited the clotting of fibrinogen by thrombin but did not affect the rate of fibrinopeptide A release, indicating that the Fab inhibits clotting by interfering with the polymerization of fibrin monomers. Our experiments suggest that fibrinogen released from platelets is directly involved in thrombin induced aggregation of washed platelets, perhaps through polymerization of fibrin monomers generated by proteolytic cleavage of released fibrinogen.

Original languageEnglish
Pages (from-to)1259-1268
Number of pages10
JournalJournal of Clinical Investigation
Volume55
Issue number6
DOIs
StatePublished - 1975

Fingerprint Dive into the research topics of 'Inhibition of human platelet aggregation by monovalent antifibrinogen antibody fragments'. Together they form a unique fingerprint.

Cite this